Familial hypercholesterolemia(FH)is an autosomal dominant genetic disorder,which resulted in severe elevations in low-density lipoprotein cholesterol(LDL-C)and a markedly increased risk of early-onset coronary disease...Familial hypercholesterolemia(FH)is an autosomal dominant genetic disorder,which resulted in severe elevations in low-density lipoprotein cholesterol(LDL-C)and a markedly increased risk of early-onset coronary disease.[1]t is most frequently caused by loss-of-function mutations in genes affecting the LDL receptor,which clears LDL particles from plasma.展开更多
Treatment of unprotected left main coronary artery(ULMCA)disease with coronary artery bypass grafting(CABG)or percutaneous coronary intervention(PCI)has developed rapidly during the past decades.The optimal revascular...Treatment of unprotected left main coronary artery(ULMCA)disease with coronary artery bypass grafting(CABG)or percutaneous coronary intervention(PCI)has developed rapidly during the past decades.The optimal revascularization strategy has been a subject of debate,with several randomized controlled trials and metaanalyses comparing outcomes of CABG and PCI.展开更多
基金the National Natural Science Foundation of China(No.81370443&No.81170793).
文摘Familial hypercholesterolemia(FH)is an autosomal dominant genetic disorder,which resulted in severe elevations in low-density lipoprotein cholesterol(LDL-C)and a markedly increased risk of early-onset coronary disease.[1]t is most frequently caused by loss-of-function mutations in genes affecting the LDL receptor,which clears LDL particles from plasma.
文摘Treatment of unprotected left main coronary artery(ULMCA)disease with coronary artery bypass grafting(CABG)or percutaneous coronary intervention(PCI)has developed rapidly during the past decades.The optimal revascularization strategy has been a subject of debate,with several randomized controlled trials and metaanalyses comparing outcomes of CABG and PCI.